Inventor

Sei Ryang Oh

Inventor

Daejeon, KR

Overview

2009–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 35 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes27%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%

A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for20%

A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation15%

A23KFodder2%

A61QSpecific use of cosmetics or similar toiletry preparations2%

B01DSeparation2%

C07CAcyclic or carbocyclic compounds2%

C07DHeterocyclic compounds2%

C07HSugars2%

PatentTitleYear

10,857,119Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis2020 10,765,655Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating chronic obstructive pulmonary disease2020 10,751,378Pharmaceutical composition comprising 2020 10,413,579Pharmaceutical composition for preventing or treating asthma comprising 2019 10,406,187Method for treating neuroinflammation with a pharmaceutical composition containing 2019 10,376,553Pharmaceutical composition for preventing and treating chronic obstructive lung disease containing, as active ingredient, 2019 10,172,816Method of treating chronic obstructive pulmonary disease (CPD) with verproside2019 10,098,864Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma2018 10,092,587Antiviral composition containing material involved in phosphatidylcholine synthesis pathway2018 10,058,527Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis2018 10,053,4432-phenylbenzofuran derivatives, method for preparing the same and use of the same for treating inflammatory disease2018 10,046,019Purified extract (ATC1) isolated from 2018 9,999,646Method of treating inflammation, allergy and asthma with a purified extract (ATC1) isolated from 2018 9,895,337'Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis'2018 9,820,963'Composition containing lignan compound as active ingredient for preventing or treating cancer'2017 9,763,908'Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating atopic dermatitis'2017 9,675,658'Method of treating inflammation, allergy and asthma with a purified extract (ATC2) isolated from Pseudolysimachion rotundam var. subintegrum containing abundant amount of active ingredient'2017 9,655,871'Composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom, as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof'2017 9,610,310'Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient'2017 9,592,263'Purified extract (ATC2) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma'2017 9,481,630'Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same'2016 9,428,520'Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis'2016 9,375,456'Antiviral composition containing an Aleurites fordii or Daphne kiusiana extract or a fraction thereof as an active ingredient'2016 9,174,925'Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same'2015 9,078,912'Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma'2015 9,061,022'Pharmaceutical composition for treating wounds or revitalizing skin comprising Euphorbia kansui extracts, fractions thereof or diterpene compounds separated from the fractions as active ingredient'2015 8,980,846'Composition containing styraxlignolide A or the aglycone thereof as an active ingredient for preventing or treating asthma'2015 8,974,837'Pharmaceutical composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity'2015 8,883,226'Pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma containing an extract of Decaspermum fruticosum'2014 8,722,110'Pharmaceutical composition for preventing or treating inflammatory diseases, allergic diseases or asthma, containing Diospyros blancoi A. DC. extract as active ingredient'2014 8,455,541'Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity'2013 8,299,049'Compositions comprising an extract of Tiarella polyphylla or compounds isolated therefrom for preventing and treating cancer diseases'2012 8,168,235'Pharmaceutical composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity'2012 7,763,286'Composition comprising an extract of Tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity'2010 7,534,456'Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2016Patents assigned to KOREA RES INST OF BIOSCIENCE (11)· patent assignee history

2009–2020Based in Daejeon, KR· patent location history

2012–2016Patents assigned to AHN KYUNG SEOP (9)· patent assignee history

2012–2016Patents assigned to OH SEI RYANG (8)· patent assignee history

2012–2015Patents assigned to LEE HYEONG KYU (7)· patent assignee history

2016–2020Patents assigned to KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (20)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY	20	2016–2020
KOREA RES INST OF BIOSCIENCE	11	2009–2016
AHN KYUNG SEOP	9	2012–2016
OH SEI RYANGself	8	2012–2016
LEE HYEONG KYU	7	2012–2015

Locations

Location	Patents	Span
Daejeon, KR	35	2009–2020